Alexandra Simon
Founder at Hunter Pacific Fund | Los Angeles, California, United States
Alexandra Simon’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Founder at Hunter Pacific Fund in April 2018 - Present
Board Member at Koning Food Industries in January 2021 - Present
Venture Partner at Catchlight Capital Partners in January 2023 - Present
Global Head at Stealth PE/VC Fund in January 2025 - Present
Partner at Cipholio Ventures in January 2021 - January 2025
Chief Strategy Officer at BitMart in January 2021 - January 2025
Board Member at Intellabridge | Karma Connect | Karma Card Corporation in January 2022 - January 2024
Advisor at UpHonest Capital in January 2020 - January 2022
Chief Investment Officer at Trepont Fund in January 2020 - January 2021
Venture Partner at Republic in January 2020 - January 2021
Chief Financial Officer at GrubMarket Inc. in October 2018 - April 2020
Senior Vice President Investment at ZZ Ventures in January 2017 - January 2018
Vice President Investment Banking at Merrill Lynch in January 2014 - January 2017
Mergers and Acquisitions Associate at Evercore in January 2011 - January 2014
Financial Analyst Investment Banking at Morgan Stanley in January 2008 - January 2009
Financial Analyst at Morgan Stanley in January 2006 - January 2008
We aspire to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. We are imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. Our global roots go back more than 350 years. Today, we have approximately 1,100 employees around the US with commercial, clinical and research operations in Massachusetts. Community Guidelines: https://bit.ly/2nbPYl1
Discover more about Hunter Pacific Fund
Drug Developer | Biostatistics, Clinical Pharmacology & Pharmacometrics, DMPK | Statistics & Pharmacometrics Special Interest Group Co-Chair
Vice President, Clinical Pharmacology at Seaport Therapeutics
(February 2025 – Present)
U.S. Brand Lead, TEPMETKO, U.S. Oncology Marketing
U.S. Brand Lead, TEPMETKO at EMD Serono, Inc.
(April 2024 – Present)
Director, Medical and Outcomes Liaison, National Accounts at EMD Serono
Director, Medical and Outcomes Liaison at EMD Serono, Inc.
(November 2018 – Present)
Oncology Drug Discovery Leader | In Vivo Pharmacology Expert | Driving Innovation in Cancer Therapeutics at EMD Serono, Inc. (Merck KGaA)
Director, Translational In Vivo Pharmacology at EMD Serono, Inc.
(May 2023 – Present)
Associate Director, Northeast Thought Leader Liaison
Associate Director, Northeast Thought Leader Liaison at ITF Therapeutics LLC
(May 2025 – Present)
Director, Forecasting, US and Global at EMD Serono, Inc.
Director, Forecasting, US and Global at EMD Serono, Inc.
(April 2024 – Present)
What is Alexandra Simon email address?
Email Alexandra Simon at [email protected]. This email is the most updated Alexandra Simon's email found in 2026.
How to contact Alexandra Simon?
To contact Alexandra Simon send an email to [email protected].
What company does Alexandra Simon work for?
Alexandra Simon works for Hunter Pacific Fund.
What is Alexandra Simon's role at Hunter Pacific Fund?
Alexandra Simon is Founder
What industry does Alexandra Simon work in?
Alexandra Simon works in the Biotechnology industry.
